Funder: National Institutes of Health

Due Dates: June 4, 2025 | September 10, 2025 | February 4, 2026 | June 4, 2026 | September 10, 2026 | February 4, 2027 | June 4, 2027 | September 10, 2027

Funding Amounts: Up to $250,000 direct costs per year, for a maximum project period of 5 years (U01 cooperative agreement mechanism).

Summary: Supports research to address preanalytical variability in biospecimen collection and handling to improve the development and validation of clinical biomarker assays.

Key Information: Clinical trials are not allowed; applications must focus on assay development/validation, not biomarker discovery or technology development.